Bisser S, N'Siesi FX, Lejon V, Preux PM, Van Nieuwenhove S, Miaka Mia Bilenge C, Būscher P (February 2007). "Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness". The Journal of Infectious Diseases. 195 (3): 322–329. doi:10.1086/510534. PMID17205469. S2CID10175400.
Keiser J, Ericsson O, Burri C (May 2000). "Investigations of the metabolites of the trypanocidal drug melarsoprol". Clinical Pharmacology and Therapeutics. 67 (5): 478–488. doi:10.1067/mcp.2000.105990. PMID10824626. S2CID24326873.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
Bisser S, N'Siesi FX, Lejon V, Preux PM, Van Nieuwenhove S, Miaka Mia Bilenge C, Būscher P (February 2007). "Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness". The Journal of Infectious Diseases. 195 (3): 322–329. doi:10.1086/510534. PMID17205469. S2CID10175400.
Keiser J, Ericsson O, Burri C (May 2000). "Investigations of the metabolites of the trypanocidal drug melarsoprol". Clinical Pharmacology and Therapeutics. 67 (5): 478–488. doi:10.1067/mcp.2000.105990. PMID10824626. S2CID24326873.
Bisser S, N'Siesi FX, Lejon V, Preux PM, Van Nieuwenhove S, Miaka Mia Bilenge C, Būscher P (February 2007). "Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness". The Journal of Infectious Diseases. 195 (3): 322–329. doi:10.1086/510534. PMID17205469. S2CID10175400.
Keiser J, Ericsson O, Burri C (May 2000). "Investigations of the metabolites of the trypanocidal drug melarsoprol". Clinical Pharmacology and Therapeutics. 67 (5): 478–488. doi:10.1067/mcp.2000.105990. PMID10824626. S2CID24326873.